Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

The firm said in May it was considering the surcharge following disclosure of a $40 million tariff-related headwind for 2025.

Adding the firm's multi-cancer early detection test to standard-of-care screening demonstrated substantially greater additional cancer detection than in Pathfinder.

The shares are expected to begin trading on June 18 under the ticker symbol CAI, and the offering is expected to close on June 20.